logo
Plus   Neg
Share
Email

McKesson To Review Cost Structure; To Buy Medical Specialties Distributors

McKesson Corp. (MCK) announced a multi-year strategic growth initiative which comprises multiple growth pillars, and includes a comprehensive review of the company's operations and cost structure, designed to increase efficiency. As a preliminary phase of implementing the strategic growth initiative, McKesson will incur restructuring and other charges in Fiscal 2019, which will impact the company's results on the basis of U.S. generally accepted accounting principles. The restructuring plan consists of after-tax GAAP charges that are estimated to be approximately $150 million to $210 million.

McKesson also announced that it has signed a definitive agreement to acquire Medical Specialties Distributors, a national distributor of infusion and medical-surgical supplies as well as biomedical services to alternate site and home health providers. The transaction is valued at $800 million, and is expected to close in the first half of fiscal 2019. McKesson expects the transaction will be modestly accretive to adjusted earnings per diluted share in fiscal 2019.

The company has reaffirmed its adjusted earnings outlook of $12.50 to $12.80 per diluted share for the fiscal year ended March 31, 2018. In the fourth quarter, the company preliminarily estimates recording GAAP after-tax net charges of approximately $0.6 billion to $1.9 billion.

For fiscal 2019, McKesson announced a preliminary target for adjusted earnings of $13.00 to $13.80 per diluted share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The restaurant industry continues to struggle in pandemic conditions with January consumer spending in restaurants well below pre-pandemic levels, according to new data released by the National Restaurant Association or NRA. Despite the slowdown in COVID-19 outbreaks and the increased distribution of vaccines, most restaurant operators do not expect a return-to-normal business conditions any time. Chico's FAS Inc. (CHS) Tuesday reported a wider year-over-year net loss for the fourth quarter. Meanwhile, Kohl's Corp.'s (KSS) fourth-quarter net income grew 29 percent from the previous year. But Abercrombie & Fitch Co.'s (ANF) fourth-quarter net income decreased 1 percent from the prior year. The U.S. Food and Drug Administration has approved the marketing of a new robotically-assisted surgical device (RASD) that can facilitate transvaginal hysterectomy in certain patients using minimally-invasive surgical instruments. The Hominis Surgical System of Memic Innovative Surgery Ltd., the U.S. subsidiary of Israeli biotechnology company memic Ltd., has been granted marketing authorization.
Follow RTT